View source for Any Phase 1 doseescalation research to judge basic safety pharmacokinetics and pharmacodynamics of AsiDNA a new firstinclass Genetic makeup repair inhibitor used intravenously in people with superior reliable tumours
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.